Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
Titel:
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
Auteur:
Geisler, Christian H. van t' Veer, Mars B. Jurlander, Jesper Walewski, Jan Tjønnfjord, Geir Itälä Remes, Maija Kimby, Eva Kozak, Tomas Polliack, Aaron Wu, Ka Lung Wittebol, Shulamiet Abrahamse-Testroote, Martine C.J. Doorduijn, Jeanette Ghidey Alemayehu, Wendimagegn van Oers, Marinus H.J.